KSHV ORF 45 Antibodies

Santa Cruz Biotechnology features a diverse variety of KSHV ORF 45 monoclonal antibodies for research focused on understanding the Kaposi's Sarcoma-associated Herpesvirus (KSHV). KSHV ORF 45 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KSHV ORF 45 plays a critical role in the viral life cycle by helping the virus evade host immune response and promote viral replication. Understanding KSHV ORF 45 function is essential for uncovering the mechanisms of KSHV pathogenesis, particularly in relation to Kaposi's sarcoma and other associated diseases. Research on KSHV ORF 45 can reveal potential therapeutic targets for treating KSHV-associated malignancies. Investigating KSHV ORF 45 interactions with host cellular proteins provides valuable insights into viral manipulation of cellular pathways. Studying KSHV ORF 45 expression patterns during different stages of infection helps map the progression of viral diseases. Examining KSHV ORF 45 localization within infected cells enhances understanding of viral protein trafficking and function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of KSHV biology and developing new therapeutic strategies.